@parryashford
Recent Posts
Archives
Categories
Latest updates
Makena®(hydroxyprogesterone) Injection
Annual Sales
Company COVIS PHARMA (AMAG)
Date of First Filing September 28, 2020Paragraph IV Applicant: Aurobindo
Case Name: COVIS PHARMA GMBH et al v. EUGIA PHARMA SPECIALTIES LTD et al
Court/Case #: Delaware District Court (dedc) 1:2021cv00003
Date Filed: 1/4/21
Judge: Connelly
Product…Read more
The Paragraph Four Report®
Paragraph IV Activity for December 2020New Certifications as reported by FDA on December 1, 2020
1. Minocin®(minocycline) Injection 100 mg/vial on 10/16/2020
Comments: Minocycline has appeared on the PIV List before but this is the first for the injection form.
New Cases Filed
1. Product: A…Read more
Pemfexy®(pemetrexed) Injection
Annual Sales
Company EAGLE
Date of First Filing Not applicableParagraph IV Applicant: Shilpa
Case Name: EAGLE PHARMACEUTICALS INC et al v. SHILPA MEDICARE LIMITED
Court/Case #: New Jersey District Course (njdc) 2:2020cv20270
Date Filed: 12/28/20
Judge: Vazquez
Product Strength: 25…Read more
Search
Latest Updates
Makena®(hydroxyprogesterone) Injection
Annual Sales
Company COVIS PHARMA (AMAG)
Date of First Filing September 28, 2020Paragraph IV Applicant: Aurobindo
Case Name: COVIS PHARMA GMBH et al v. EUGIA PHARMA SPECIALTIES LTD et al
Court/Case #: Delaware District Court (dedc) 1:2021cv00003
Date Filed: 1/4/21
Judge: Connelly
Product…Read more
The Paragraph Four Report®
Paragraph IV Activity for December 2020New Certifications as reported by FDA on December 1, 2020
1. Minocin®(minocycline) Injection 100 mg/vial on 10/16/2020
Comments: Minocycline has appeared on the PIV List before but this is the first for the injection form.
New Cases Filed
1. Product: A…Read more
Pemfexy®(pemetrexed) Injection
Annual Sales
Company EAGLE
Date of First Filing Not applicableParagraph IV Applicant: Shilpa
Case Name: EAGLE PHARMACEUTICALS INC et al v. SHILPA MEDICARE LIMITED
Court/Case #: New Jersey District Course (njdc) 2:2020cv20270
Date Filed: 12/28/20
Judge: Vazquez
Product Strength: 25…Read more
Login
Search Forums
Login
Latest updates
Makena®(hydroxyprogesterone) Injection
Annual Sales
Company COVIS PHARMA (AMAG)
Date of First Filing September 28, 2020Paragraph IV Applicant: Aurobindo
Case Name: COVIS PHARMA GMBH et al v. EUGIA PHARMA SPECIALTIES LTD et al
Court/Case #: Delaware District Court (dedc) 1:2021cv00003
Date Filed: 1/4/21
Judge: Connelly
Product…Read more
The Paragraph Four Report®
Paragraph IV Activity for December 2020New Certifications as reported by FDA on December 1, 2020
1. Minocin®(minocycline) Injection 100 mg/vial on 10/16/2020
Comments: Minocycline has appeared on the PIV List before but this is the first for the injection form.
New Cases Filed
1. Product: A…Read more
Pemfexy®(pemetrexed) Injection
Annual Sales
Company EAGLE
Date of First Filing Not applicableParagraph IV Applicant: Shilpa
Case Name: EAGLE PHARMACEUTICALS INC et al v. SHILPA MEDICARE LIMITED
Court/Case #: New Jersey District Course (njdc) 2:2020cv20270
Date Filed: 12/28/20
Judge: Vazquez
Product Strength: 25…Read more
Login
Latest updates
Makena®(hydroxyprogesterone) Injection
Annual Sales
Company COVIS PHARMA (AMAG)
Date of First Filing September 28, 2020Paragraph IV Applicant: Aurobindo
Case Name: COVIS PHARMA GMBH et al v. EUGIA PHARMA SPECIALTIES LTD et al
Court/Case #: Delaware District Court (dedc) 1:2021cv00003
Date Filed: 1/4/21
Judge: Connelly
Product…Read more
The Paragraph Four Report®
Paragraph IV Activity for December 2020New Certifications as reported by FDA on December 1, 2020
1. Minocin®(minocycline) Injection 100 mg/vial on 10/16/2020
Comments: Minocycline has appeared on the PIV List before but this is the first for the injection form.
New Cases Filed
1. Product: A…Read more
Pemfexy®(pemetrexed) Injection
Annual Sales
Company EAGLE
Date of First Filing Not applicableParagraph IV Applicant: Shilpa
Case Name: EAGLE PHARMACEUTICALS INC et al v. SHILPA MEDICARE LIMITED
Court/Case #: New Jersey District Course (njdc) 2:2020cv20270
Date Filed: 12/28/20
Judge: Vazquez
Product Strength: 25…Read more
Recent Comments